Literature DB >> 16920915

Double-negative T regulatory cells can develop outside the thymus and do not mature from CD8+ T cell precursors.

Megan S Ford1, Zhu-Xu Zhang, Wenhao Chen, Li Zhang.   

Abstract

Recent studies have demonstrated that activated peripheral alphabeta TCR+ CD3+ CD4- CD8- NK1.1- (double-negative, DN) regulatory T cells (Tregs) from both mice and humans are able to down-regulate immune responses in vitro and in vivo. However, the origin and developmental requirements of functional DN Tregs remain unclear. In this study, we investigated the requirement for CD8 expression as well as the presence of a thymus for the development of functional DN Tregs. We demonstrate that DN Tregs exist in CD8-deficient mice and that stimulation of CD8+ T cells in vivo with TCR-specific Ag does not convert CD8+ T cells into DN Tregs. In addition, we found that DN T cells are present in the spleens and lymph nodes of thymectomized mice that are irradiated and reconstituted with T cell-depleted bone marrow cells. Interestingly, DN Tregs that develop in thymectomized mice can suppress syngeneic CD8+ T cells more effectively than those that develop in sham-thymectomized mice. Taken together, our data suggest that DN Tregs are not derived from CD8+ T cell precursors and that functional DN Tregs may preferentially develop outside of the thymus. These data suggest that DN Tregs may represent a developmentally and functionally unique cell population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920915     DOI: 10.4049/jimmunol.177.5.2803

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions.

Authors:  Stephen C Juvet; Li Zhang
Journal:  J Mol Cell Biol       Date:  2012-02       Impact factor: 6.216

2.  New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses.

Authors:  Dong Zhang; Wei Yang; Nicolas Degauque; Yan Tian; Allison Mikita; Xin Xiao Zheng
Journal:  Blood       Date:  2006-12-29       Impact factor: 22.113

3.  Programmed cell death 1 and Helios distinguish TCR-αβ+ double-negative (CD4-CD8-) T cells that derive from self-reactive CD8 T cells.

Authors:  Noé Rodríguez-Rodríguez; Sokratis A Apostolidis; Pablo Penaloza-MacMaster; José Manuel Martín Villa; Dan H Barouch; George C Tsokos; José C Crispín
Journal:  J Immunol       Date:  2015-03-30       Impact factor: 5.422

Review 4.  T regulatory cells and transplantation tolerance.

Authors:  Vijay S Gorantla; Stefan Schneeberger; Gerald Brandacher; Robert Sucher; Dong Zhang; W P Andrew Lee; Xin Xiao Zheng
Journal:  Transplant Rev (Orlando)       Date:  2010-06-11       Impact factor: 3.943

5.  Unusual selection and peripheral homeostasis for immunoregulatory CD4(-)  CD8(-) T cells.

Authors:  Véronique Dugas; Geneviève Chabot-Roy; Claudine Beauchamp; Fanny Guimont-Desrochers; Erin E Hillhouse; Adrian Liston; Sylvie Lesage
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

6.  Double-negative T resident memory cells of the lung react to influenza virus infection via CD11c(hi) dendritic cells.

Authors:  K Neyt; C H GeurtsvanKessel; B N Lambrecht
Journal:  Mucosal Immunol       Date:  2015-09-16       Impact factor: 7.313

7.  TCR-α/β CD4- CD8- double negative T cells arise from CD8+ T cells.

Authors:  Noé Rodríguez-Rodríguez; Giovanna Flores-Mendoza; Sokratis A Apostolidis; Florencia Rosetti; George C Tsokos; José C Crispín
Journal:  J Leukoc Biol       Date:  2020-02-13       Impact factor: 4.962

8.  Concomitant Disruption of CD4 and CD8 Genes Facilitates the Development of Double Negative αβ TCR+ Peripheral T Cells That Respond Robustly to Staphylococcal Superantigen.

Authors:  Vaidehi R Chowdhary; Ashton Krogman; Ashenafi Y Tilahun; Mariam P Alexander; Chella S David; Govindarajan Rajagopalan
Journal:  J Immunol       Date:  2017-05-03       Impact factor: 5.422

9.  Double negative (CD3+ 4- 8-) TCR alphabeta splenic cells from young NOD mice provide long-lasting protection against type 1 diabetes.

Authors:  Beverly Duncan; Cristina Nazarov-Stoica; Jacqueline Surls; Margaret Kehl; Constantin Bona; Sofia Casares; Teodor-D Brumeanu
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

10.  Characterization of MHC class-I restricted TCRalphabeta+ CD4- CD8- double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination.

Authors:  Simon Voelkl; Tamson V Moore; Michael Rehli; Michael I Nishimura; Andreas Mackensen; Karin Fischer
Journal:  Cancer Immunol Immunother       Date:  2008-10-03       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.